Intensity Therapeutics, Inc. (INTS)
CIK 1567264 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Intensity Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 11, 2026 | 10-Q | 0001567264-26-000059 |
| Aug 11, 2026 | 8-K | 0001567264-26-000061 |
| Jul 20, 2026 | 4 | 0001231945-26-000002 |
| Jul 20, 2026 | 4 | 0001875180-26-000002 |
| Jul 20, 2026 | 4 | 0001524547-26-000009 |
| Jul 20, 2026 | 4 | 0001238705-26-000007 |
| Jul 20, 2026 | 4 | 0001934188-26-000002 |
| Jul 20, 2026 | 4 | 0001278042-26-000002 |
| Jul 20, 2026 | 4 | 0001895944-26-000008 |
| Jul 8, 2026 | S-8 | 0001567264-26-000054 |
| Jul 1, 2026 | 4 | 0001524547-26-000007 |
| Jul 1, 2026 | 4 | 0001895944-26-000006 |
| Jun 16, 2026 | 8-K | 0001567264-26-000049 |
| May 7, 2026 | 10-Q | 0001567264-26-000046 |
| May 7, 2026 | 8-K | 0001567264-26-000047 |
| Apr 30, 2026 | DEF 14A | 0001567264-26-000035 |
| Apr 30, 2026 | DEFA14A | 0001567264-26-000036 |
| Apr 30, 2026 | ARS | 0001567264-26-000037 |
| Mar 30, 2026 | 4 | 0001238705-26-000005 |
| Mar 27, 2026 | 10-K | 0001567264-26-000024 |
| Mar 27, 2026 | 8-K | 0001567264-26-000025 |
| Mar 23, 2026 | 424B5 | 0001567264-26-000020 |
| Mar 23, 2026 | 8-K | 0001567264-26-000021 |
| Mar 6, 2026 | 8-K | 0001567264-26-000014 |
| Mar 5, 2026 | 8-K | 0001567264-26-000011 |